List of Tables
Table 1. Cell and Gene Therapy Manufacturing QC Market Trends
Table 2. Cell and Gene Therapy Manufacturing QC Market Drivers & Opportunity
Table 3. Cell and Gene Therapy Manufacturing QC Market Challenges
Table 4. Cell and Gene Therapy Manufacturing QC Market Restraints
Table 5. Global Cell and Gene Therapy Manufacturing QC Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Cell and Gene Therapy Manufacturing QC Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Cell and Gene Therapy Manufacturing QC Product Type
Table 9. Key Companies Time to Begin Mass Production of Cell and Gene Therapy Manufacturing QC
Table 10. Global Cell and Gene Therapy Manufacturing QC Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Manufacturing QC as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Cell and Gene Therapy Manufacturing QC Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Cell and Gene Therapy Manufacturing QC Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Cell and Gene Therapy Manufacturing QC Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Cell and Gene Therapy Manufacturing QC Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Cell and Gene Therapy Manufacturing QC Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Cell and Gene Therapy Manufacturing QC Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Cell and Gene Therapy Manufacturing QC Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Cell and Gene Therapy Manufacturing QC Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Cell and Gene Therapy Manufacturing QC Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Cell and Gene Therapy Manufacturing QC Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Cell and Gene Therapy Manufacturing QC Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Cell and Gene Therapy Manufacturing QC Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Cell and Gene Therapy Manufacturing QC Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Cell and Gene Therapy Manufacturing QC Sales Value by Region (2019-2024) & (%)
Table 27. Global Cell and Gene Therapy Manufacturing QC Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Cell and Gene Therapy Manufacturing QC Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Cell and Gene Therapy Manufacturing QC Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Cell and Gene Therapy Manufacturing QC Sales Value, (2025-2030) & (US$ Million)
Table 31. Bio-Techne Corporation Basic Information List
Table 32. Bio-Techne Corporation Description and Business Overview
Table 33. Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Products, Services and Solutions
Table 34. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing QC Business of Bio-Techne Corporation (2019-2024)
Table 35. Bio-Techne Corporation Recent Developments
Table 36. BioMerieux SA Basic Information List
Table 37. BioMerieux SA Description and Business Overview
Table 38. BioMerieux SA Cell and Gene Therapy Manufacturing QC Products, Services and Solutions
Table 39. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing QC Business of BioMerieux SA (2019-2024)
Table 40. BioMerieux SA Recent Developments
Table 41. Catalent, Inc. Basic Information List
Table 42. Catalent, Inc. Description and Business Overview
Table 43. Catalent, Inc. Cell and Gene Therapy Manufacturing QC Products, Services and Solutions
Table 44. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing QC Business of Catalent, Inc. (2019-2024)
Table 45. Catalent, Inc. Recent Developments
Table 46. Charles River Laboratories International Inc. Basic Information List
Table 47. Charles River Laboratories International Inc. Description and Business Overview
Table 48. Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Products, Services and Solutions
Table 49. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing QC Business of Charles River Laboratories International Inc. (2019-2024)
Table 50. Charles River Laboratories International Inc. Recent Developments
Table 51. Eurofins Scientific SE Basic Information List
Table 52. Eurofins Scientific SE Description and Business Overview
Table 53. Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Products, Services and Solutions
Table 54. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing QC Business of Eurofins Scientific SE (2019-2024)
Table 55. Eurofins Scientific SE Recent Developments
Table 56. F. Hoffmann-La Roche Ltd Basic Information List
Table 57. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 58. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Products, Services and Solutions
Table 59. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing QC Business of F. Hoffmann-La Roche Ltd (2019-2024)
Table 60. F. Hoffmann-La Roche Ltd Recent Developments
Table 61. Intertek Group plc Basic Information List
Table 62. Intertek Group plc Description and Business Overview
Table 63. Intertek Group plc Cell and Gene Therapy Manufacturing QC Products, Services and Solutions
Table 64. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing QC Business of Intertek Group plc (2019-2024)
Table 65. Intertek Group plc Recent Developments
Table 66. Lonza Group AG Basic Information List
Table 67. Lonza Group AG Description and Business Overview
Table 68. Lonza Group AG Cell and Gene Therapy Manufacturing QC Products, Services and Solutions
Table 69. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing QC Business of Lonza Group AG (2019-2024)
Table 70. Lonza Group AG Recent Developments
Table 71. Merck KGaA Basic Information List
Table 72. Merck KGaA Description and Business Overview
Table 73. Merck KGaA Cell and Gene Therapy Manufacturing QC Products, Services and Solutions
Table 74. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing QC Business of Merck KGaA (2019-2024)
Table 75. Merck KGaA Recent Developments
Table 76. Sartorius AG Basic Information List
Table 77. Sartorius AG Description and Business Overview
Table 78. Sartorius AG Cell and Gene Therapy Manufacturing QC Products, Services and Solutions
Table 79. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing QC Business of Sartorius AG (2019-2024)
Table 80. Sartorius AG Recent Developments
Table 81. SGS S.A. Basic Information List
Table 82. SGS S.A. Description and Business Overview
Table 83. SGS S.A. Cell and Gene Therapy Manufacturing QC Products, Services and Solutions
Table 84. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing QC Business of SGS S.A. (2019-2024)
Table 85. SGS S.A. Recent Developments
Table 86. Sistemic Scotland Limited Basic Information List
Table 87. Sistemic Scotland Limited Description and Business Overview
Table 88. Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Products, Services and Solutions
Table 89. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing QC Business of Sistemic Scotland Limited (2019-2024)
Table 90. Sistemic Scotland Limited Recent Developments
Table 91. Thermo Fisher Scientific Inc. Basic Information List
Table 92. Thermo Fisher Scientific Inc. Description and Business Overview
Table 93. Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Products, Services and Solutions
Table 94. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing QC Business of Thermo Fisher Scientific Inc. (2019-2024)
Table 95. Thermo Fisher Scientific Inc. Recent Developments
Table 96. Vigene Biosciences, Inc. Basic Information List
Table 97. Vigene Biosciences, Inc. Description and Business Overview
Table 98. Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Products, Services and Solutions
Table 99. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing QC Business of Vigene Biosciences, Inc. (2019-2024)
Table 100. Vigene Biosciences, Inc. Recent Developments
Table 101. WuXi AppTec Basic Information List
Table 102. WuXi AppTec Description and Business Overview
Table 103. WuXi AppTec Cell and Gene Therapy Manufacturing QC Products, Services and Solutions
Table 104. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing QC Business of WuXi AppTec (2019-2024)
Table 105. WuXi AppTec Recent Developments
Table 106. Key Raw Materials Lists
Table 107. Raw Materials Key Suppliers Lists
Table 108. Cell and Gene Therapy Manufacturing QC Downstream Customers
Table 109. Cell and Gene Therapy Manufacturing QC Distributors List
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
Table 113. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Cell and Gene Therapy Manufacturing QC Product Picture
Figure 2. Global Cell and Gene Therapy Manufacturing QC Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Cell and Gene Therapy Manufacturing QC Sales Value (2019-2030) & (US$ Million)
Figure 4. Cell and Gene Therapy Manufacturing QC Report Years Considered
Figure 5. Global Cell and Gene Therapy Manufacturing QC Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Cell and Gene Therapy Manufacturing QC Revenue in 2023
Figure 7. Cell and Gene Therapy Manufacturing QC Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Safety Testing Picture
Figure 9. Purity Testing Picture
Figure 10. Potency Testing Picture
Figure 11. Identity Testing Picture
Figure 12. Stability Testing Picture
Figure 13. Global Cell and Gene Therapy Manufacturing QC Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Cell and Gene Therapy Manufacturing QC Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of Precision Therapy
Figure 16. Product Picture of Biological Research
Figure 17. Global Cell and Gene Therapy Manufacturing QC Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Cell and Gene Therapy Manufacturing QC Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Cell and Gene Therapy Manufacturing QC Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Cell and Gene Therapy Manufacturing QC Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Cell and Gene Therapy Manufacturing QC Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Cell and Gene Therapy Manufacturing QC Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Cell and Gene Therapy Manufacturing QC Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Cell and Gene Therapy Manufacturing QC Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Cell and Gene Therapy Manufacturing QC Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Cell and Gene Therapy Manufacturing QC Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Cell and Gene Therapy Manufacturing QC Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Cell and Gene Therapy Manufacturing QC Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Cell and Gene Therapy Manufacturing QC Sales Value (%), (2019-2030)
Figure 30. United States Cell and Gene Therapy Manufacturing QC Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Cell and Gene Therapy Manufacturing QC Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Cell and Gene Therapy Manufacturing QC Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Cell and Gene Therapy Manufacturing QC Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Cell and Gene Therapy Manufacturing QC Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Cell and Gene Therapy Manufacturing QC Sales Value by Application (%), 2023 VS 2030
Figure 36. China Cell and Gene Therapy Manufacturing QC Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Cell and Gene Therapy Manufacturing QC Sales Value by Type (%), 2023 VS 2030
Figure 38. China Cell and Gene Therapy Manufacturing QC Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Cell and Gene Therapy Manufacturing QC Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Cell and Gene Therapy Manufacturing QC Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Cell and Gene Therapy Manufacturing QC Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Cell and Gene Therapy Manufacturing QC Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Cell and Gene Therapy Manufacturing QC Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Cell and Gene Therapy Manufacturing QC Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Cell and Gene Therapy Manufacturing QC Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Cell and Gene Therapy Manufacturing QC Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Cell and Gene Therapy Manufacturing QC Sales Value by Application (%), 2023 VS 2030
Figure 48. India Cell and Gene Therapy Manufacturing QC Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Cell and Gene Therapy Manufacturing QC Sales Value by Type (%), 2023 VS 2030
Figure 50. India Cell and Gene Therapy Manufacturing QC Sales Value by Application (%), 2023 VS 2030
Figure 51. Cell and Gene Therapy Manufacturing QC Industrial Chain
Figure 52. Cell and Gene Therapy Manufacturing QC Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
